Jiangsu Bioperfectus Technologies Co.,Ltd.’s Net Profit Rose 63.1% in First Three Quarters of 2022
Listen to the full version

Jiangsu Bioperfectus Technologies Co.,Ltd. (江苏硕世生物科技股份有限公司) (688399.SH) reported a net profit of 1.6 billion yuan in the first three quarters of 2022, up 63.1% year-on-year.
Meanwhile, the company posted 4.3 billion yuan in revenue, up 97.7% year-on-year.
At the end of the reporting period, it had 4.7 billion yuan in total assets and 1.1 billion yuan in total liabilities, with a liability-to-asset ratio of 23.1%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR